Acquiring Company
Alfasigma
Acquired Company
Nordic Pharma
Bologna
BerwynManufacturingBiotechnologyHealth CareBiotechnologyHealth CareDescription
Alfasigma has announced its acquisition of Nordic Pharma to enter the Japanese and Canadian markets. The Italian drugmaker aims to enhance its global portfolio with Nordic Pharma's specialized products in rheumatology and women's health. The deal, valued at an undisclosed amount, is expected to close before the end of 2026, pending regulatory approval. This acquisition aligns with Alfasigma's strategy of targeting smaller pharmaceutical firms for growth.
Who to call at Alfasigma, and when
When Alfasigma changes hands, the new owners review vendors, systems and leadership. That is when the door opens.
- An alert the day Alfasigma raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Alfasigma, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Alfasigma. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Alfasigma makes an acquisition, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Frequently asked
Who acquired Nordic Pharma?
Nordic Pharma was acquired by Alfasigma, based in Bologna. The deal was reported on August 15, 2026. Alfasigma is one of Italy's leading pharmaceutical companies with a strong international position. Alfasigma is privately held and operates in Manufacturing.
When did Alfasigma acquire Nordic Pharma?
Alfasigma's acquisition of Nordic Pharma was reported on August 15, 2026. Alfasigma has announced its acquisition of Nordic Pharma to enter the Japanese and Canadian markets. The Italian drugmaker aims to enhance its global portfolio with Nordic Pharma's specialized products in rheumatology and women's health. Fundz records the date the transaction was first publicly reported, sourced from filings and company announcements.
What does Nordic Pharma do?
Nordic Pharma, Inc. is committed to engaging ophthalmologists and optometrists in the early launch stages of LACRIFILL Canalicular Gel. It is privately held, operating in Biotechnology, and is based in Berwyn.
This company was part of an acquisition. Fundz tracks who bought whom, and who to call on both sides.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.